Candace S. Howell
About Candace S. Howell
Candace S. Howell is the Engagement Strategy Lead at Bristol-Myers Squibb in the Greater New York City Area, with a background in communications and public health.
Company
Candace S. Howell currently works at Bristol-Myers Squibb as an Engagement Strategy Lead in the Greater New York City Area. Her role focuses on developing and implementing strategies to enhance stakeholder engagement within the company.
Title
Candace S. Howell holds the title of Engagement Strategy Lead at Bristol-Myers Squibb. Her responsibilities likely include overseeing engagement initiatives and ensuring effective communication strategies are in place.
Education and Expertise
Candace S. Howell studied Philosophy and achieved a Bachelor of Arts (B.A.) from Dartmouth College. She also holds a Master of Public Health (M.P.H.) in Policy and Management from Columbia University in the City of New York. Additionally, she participated in a Foreign Exchange Program at Universidad de Granada. Her educational background equips her with a strong foundation in public health policy, management, and philosophical perspectives.
Professional Background
Candace S. Howell has an extensive professional background across various organizations. She worked at CSH Communications as an Independent Consultant from 2016 to 2019 in New York, NY/Washington, DC. She served as Director of Communications at Avalere Health from 2014 to 2015 in Washington, D.C./New York, NY. At Pfizer, she held several strategic roles, including Senior Manager/Lead for Oncology Products & Medical Emerging Markets from 2011 to 2012, Director of Communications for the Emerging Markets - Europe, Africa, Asia & Latin America from 2008 to 2011, and Director of External Affairs, Medical Division from 2002 to 2008. Early in her career, she worked as a Senior Associate at PwC from 1998 to 2001 in New York, NY.
Achievements
Candace S. Howell has been recognized for her leadership and engagement abilities by both corporations and non-profits. She developed recruitment strategies focusing on creating positive site and patient experiences in clinical trials and managed a team of 15 in-country communicators to implement market access strategies for oncology products in over 25 emerging markets. Additionally, she conceptualized and drove a brand reputation strategy involving stakeholder mapping to demonstrate the value proposition of a global organization. She has also served as a speaker at trade conferences and represented her company with the media, and she is a member of national trade and advisory boards.